Management of Lupus Nephritis: New Treatments and Updated Guidelines-Reference-Cited by-同舟云学术

Management of Lupus Nephritis: New Treatments and Updated Guidelines

Published:2023-10 Issue:10 Volume:4 Page:1503-1511
ISSN:2641-7650
Container-title:Kidney360
language:en
Short-container-title:Kidney360

Author:

Avasare Rupali¹^ORCID,Drexler Yelena²^ORCID,Caster Dawn J.³,Mitrofanova Alla²^ORCID,Jefferson J. Ashley⁴

Affiliation:

1. Nephrology and Hypertension, Oregon Health & Science University School of Medicine, Portland, Oregon

2. Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida

3. Division of Nephrology and Hypertension, University of Louisville School of Medicine, Louisville, Kentucky

4. Division of Nephrology, University of Washington, Seattle, Washington

Abstract

Management of lupus nephritis has evolved considerably over the past years. Here, we provide a comprehensive review of clinical trials that form the basis for the Kidney Disease: Improving Global Outcomes and EULAR/ERA-EDTA updated guidelines and present day trials that will change the landscape of lupus nephritis therapy in years to come. In addition, we highlight the issues related to cost of therapy, resistant disease, and downstream adverse effects of specific therapies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Neuropsychology and Physiological Psychology

Reference87 articles.

1. The frequency and outcome of lupus nephritis: results from an international inception cohort study;Hanly;Rheumatology (Oxford).,2016

2. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis;Tektonidou;Arthritis Rheumatol.,2016

3. Anti-C1q antibodies in systemic lupus erythematosus;Orbai;Lupus.,2015

4. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis;Moroni;Ann Rheum Dis.,2009

5. Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?;Cunha;Nephrol Dial Transplant.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus Nephritis from Pathogenesis to New Therapies: An Update;International Journal of Molecular Sciences;2024-08-18

2. Anti-Smith Antibodies as a Predictive Factor for Developing Lupus Nephritis in Systemic Lupus Erythematosus Patients: A Systematic Review;Cureus;2024-08-06

3. Proposal of a novel cardiovascular risk prediction score in lupus nephritis;Frontiers in Immunology;2024-07-24

4. Efficacy and safety of telitacicept in patients with lupus nephritis;Experimental and Therapeutic Medicine;2024-07-23

5. Canonical and noncanonical functions of complement in systemic lupus erythematosus;European Journal of Immunology;2024-04-17